Absci Corporation
ABSI
$-0.13
Change (1 day)
$6.72
Year High
$1.35
Year Low
Categories
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
Earnings for Absci Corporation (ABSI)
Earnings in 2023 (TTM): $-110,466,000
According to Absci Corporation's latest financial reports the company's current earnings (TTM) are $-110,466,000. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Absci Corporation
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $-110,466,000 | $-110,566,000 |
| 2022 | $-105,365,000 | $-104,904,000 |
| 2021 | $-109,859,000 | $-100,960,000 |
| 2020 | $-14,353,000 | $-14,569,000 |
| 2019 | $-6,584,000 | $-6,801,000 |